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important pathways in the process and contribute 
to attenuated response of newborn PMN to LPS in 
vitro. 
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Infection and Distribution Patterns of Beta and 
Gamma Herpesviruses in Waldeyer's Ring Tissue 
C. Berger*, M. Hug, D. Nadat. Division o[In[ectious 
Diseases, University Children's Hospital of Zurich, 
8032 ZUrich, Switzerland 
Background: The Lymphoid tissue of the orophar- 
ynx acts as a portal of entry and exit and as reser- 
voir for the human beta and gamma herpesviruses 
(HHV) foLLowing primary infection and estabLish- 
ment of Latency. 
Objective: To elucidate frequencies and quantities 
of the human beta HHV (HHV-5, -6, -7) and gamma 
HHV (HHV-4, -8) in adenoids and palatine tonsils. 
Methods: We determined the presence and the 
quantities of HHV-4, -5, -6, -7 and -8 in autoLogous 
adenoids and palatine tonsils from children under- 
going three-tonsiLLectomy for medical reasons using 
in-house established quantitative poLymerase chain 
reaction assays with Lower detection Limits ranging 
between 2 and 10 HHV DNA copies/~g DNA. 
Results: HHV-4 (Epstein-Barr virus) was detected 
in 80% of the organs from 30 children, HHV-5 (cy- 
tomegaLovirus) in 637o, and HHV-6 and HHV-7 in 77% 
each. HHV-8 was not detected. If detectable in a 
patient, HHV-4 was found in 73% in both adenoid 
and tonsils, HHV-5 in 237O, HHV-6 in 407O, and HHV-7 
in 53%. The number of DNA copies of a given HHV in 
autoLogous adenoids and tonsils significantly corre- 
Lated for HHV-4 and HHV-7 (p = 0.04 and p = 0.0007, 
respectively), but not for HHV-5 and HHV-6. The 
HHV DNA LeveLs correlated between HHV-5 and 
HHV-6 in adenoids and tonsils (p = 0.01 and p = 0.02, 
respectively) and between HHV-5 and HHV-7 in 
tonsils (p = 0.04), but not between other HHV. 
Conclusions: The different correlations of quanti- 
tative contents in autoLogous adenoids and tonsils 
suggest for HHV-5 and HHV-6 infection and distri- 
bution patterns distinct from those of HHV-4 and 
HHV-7. 
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Sequential Intravenous/Oral Cephalosporins 
in Dimercaptosuccinic Acid (DMSA) 
Scintigraphy-documented Acute Pyelonephritis 
in Children 
C. Berger, K. Buechner, E. Girardin*, U. WiLLi, 
T.J. Neuhaus, D. NadaL For the Swiss 
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Background: No study has assessed the efficacy and 
safety of oral antibiotics in children with DMSA- 
documented pyeLonephritis. 
Objectives: To compare efficacy and safety of oral 
versus sequential intravenous/oraL cephatosporin 
treatment of acute pyeLonephritis in children. 
Methods: 235 children aged 6 months to 16 years 
with a febrile urinary tract infection - rectal tem- 
perature >38 °, C-reactive protein (CRP) >10mg/t, 
and bacterial growth in cultures from urine coL- 
Lected by catheter - were prospectively randomly 
assigned to receive either intravenous ceftriaxone 
(50 mg/kg once daily) for 3 days, foLLowed by oral 
ceftibuten (9 mg/kg once daily) for 11 days or oral 
ceftibuten for 14 days. A first DMSA scintigraphy to 
detect acute renal Lesions was performed within 
5 days. Micturition cystogram and 2nd DMSA were 
performed after 6 weeks and 6 months, respec- 
tively. ExcLusion criteria were complex renal maL- 
formations and septicat appearance. 
Results: 150 children (64?o; 132 females (f) and 
18 males (m); median age 25 months, range 6-189) 
had acute renal Lesions on DMSA. 71 (47%; 61 f, 
10 m; median age 20 months) were given cetri- 
axone/ceftibuten, 79 (53%; 71 f, 8 m; median 
age 27 months) ceftibuten. One patient from the 
oral regimen only had to be switched to intra- 
venous therapy due to repeated vomiting. The 
2nd DMSA showed persistent Lesions (scars) in 
33 children (46?o; 29 f, 4 m) treated with ceftriax- 
one/ceftibuten versus 19 (24%; 18 f, 1 m) treated 
with ceftibuten (p = 0.004). 
Conclusions: In children with DMSA-documented 
pyeLonephritis, oral antibiotic therapy for 14 days 
with once daily ceftibuten is effective, safe 
and convenient, and resulted in significantly 
tess renal scars than sequential intravenous/oraL 
cephatosporin therapy. 
